Silicone Foam Dressings Significantly Reduce Pressure Injury Risk: Study

10 RCTs were included according to the inclusion criteria, and 4,817 patients were covered under them. The patients numbered 2,670 for the silicone foam dressings, and the rest were given the normal preventive treatment. RevMan 5.4 software was used to analyze the data with a focus on stage I and stage II (and higher) pressure injuries in the sacral and heel areas.

Key Findings

The meta-analysis identified a definite advantage of silicone foam dressings:

Stage I pressure injuries

• Sacral area: Relative risk (RR) = 0.18, 95% CI: 0.09–0.33, p < 0.001

• Heel area: RR = 0.30, 95% CI: 0.14–0.66, p = 0.003

Stage II and higher pressure injuries

• Sacral area: RR = 0.42, 95% CI: 0.31–0.58, p < 0.001

• Heel area: RR = 0.52, 95% CI: 0.27–0.99, p = 0.05

Silicone foam dressings were efficacious in their ability to reduce early and severe pressure injuries in the sacral and heel areas. Because of their preventive advantage, it is advised they be used clinically in high-risk patient populations. Further study on their economic and long-term effects is needed to better solidify implementation strategies within diverse healthcare environments.

Reference:

Fu, T., Wu, X., & Yu, B. (2025). Efficacy of silicone foam dressings in preventing pressure injuries in the sacral and heel areas of patients: a meta-analysis. Frontiers in Medicine, 12(1644290). https://doi.org/10.3389/fmed.2025.1644290